FDA Drug Approval, N017469, OMNIPRED
FDA Drug Approval, N017469, OMNIPRED
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 017469
Company: SANDOZ
Drug Name: OMNIPRED
Active Ingredients: PREDNISOLONE ACETATE
Strength: 1%
Dosage Form/Route: SUSPENSION/DROPS;OPHTHALMIC
Action Date: 07/10/1973
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: SANDOZ
Drug Name: OMNIPRED
Active Ingredients: PREDNISOLONE ACETATE
Strength: 1%
Dosage Form/Route: SUSPENSION/DROPS;OPHTHALMIC
Action Date: 07/10/1973
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details